Cytiva has expanded its Fast Trak process development and training facility in Bengaluru, reinforcing its commitment to supporting India’s rapidly advancing biopharmaceutical ecosystem and accelerating the development of biologics and biosimilars.

The expanded Fast Trak centre features approximately 20,000 square feet of laboratory space and integrates upstream and downstream process development, optimisation, scale up, validation services and technical training within a single facility. The centre is designed to provide biopharma companies with hands on expertise, practical training and process support to accelerate therapeutic development and manufacturing readiness.

The inauguration ceremony was attended by Pierre Alain Ruffieux, who marked the opening alongside Rhonda Duffy of Biocon Biologics during a ribbon cutting ceremony highlighting industry collaboration and innovation.

Speaking at the launch, Ruffieux emphasised the importance of strengthening development infrastructure in emerging biopharma hubs.

“India plays a pivotal role in the global biopharma landscape,” said Ruffieux. “The country has evolved from being primarily a large scale pharmaceutical manufacturing base to developing the scientific and technological capabilities required for modern biologics. By bringing Fast Trak to India, we aim to help our customers innovate faster, overcome development challenges and ultimately improve access to life saving medicines.”

The facility will provide integrated services spanning bioprocess development, optimisation and scale up, supporting companies working across biologics, biosimilars and advanced therapies. Industry leaders participating in the inauguration also highlighted the growing need for speed, flexibility and technical capability as the biosimilars market continues to expand globally.

India’s rising prominence in global biopharma innovation is increasingly reflected in industry benchmarks. According to Cytiva’s Biopharma Index, India entered the top ten global biopharma markets for the first time in 2025, reflecting growing investment in biologics research, manufacturing capabilities and development expertise.

The Bengaluru Fast Trak centre will serve as a regional hub for training and technical collaboration, helping biopharma innovators accelerate development timelines, strengthen manufacturing readiness and bring new therapies to patients faster.

The inauguration event was attended by industry experts and leaders including Beate Mueller Tiemann, Joon Ho Choi, Manoj Kumar R Panicker and Ruta Waghmare.

The expanded facility underscores Cytiva’s long term commitment to strengthening bioprocessing capabilities across Asia Pacific and supporting the next phase of India’s biologics driven growth in the global life sciences sector.